Diagnosis of tuberous sclerosis in the prenatal period: a retrospective study of 240 cases and review of the literature.
Journal
European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235
Informations de publication
Date de publication:
28 May 2024
28 May 2024
Historique:
received:
13
11
2023
accepted:
09
05
2024
revised:
04
05
2024
medline:
29
5
2024
pubmed:
29
5
2024
entrez:
28
5
2024
Statut:
aheadofprint
Résumé
Tuberous sclerosis complex (TSC) is a rare multisystemic disorder caused by a pathogenic variant in the TSC1 or TSC2 gene. A great phenotypic variability characterises TSC. The condition predisposes to the formation of hamartomas in various tissues, neurologic and neurodevelopmental disorders such as epilepsy, psychiatric disorders, as well as intellectual disability in 50%. TSC may be responsible for cardiac rhabdomyomas (CRs), cortical tubers, or subependymal nodules during foetal life. Detecting multiple CRs is associated with a very high risk of TSC, but the CR could be single and isolated. Few data exist to estimate the risk of TSC in these cases. We report the largest series of prenatal genetic tests for TSC with a retrospective study of 240 foetuses presenting with suggestive antenatal signs. We also provide a review of the literature to specify the probability of clinical or genetic diagnosis of TSC in case of detection of single or multiple CRs. Indeed, an early diagnosis is crucial for the counselling of the couple and their families. In this series, a definite diagnosis was assessed in 50% (41/82) of foetuses who initially presented with a single CR and 80.3% (127/158) in cases of multiple CRs. The prevalence of parental germinal mosaicism was 2.6% (3/115).
Identifiants
pubmed: 38806662
doi: 10.1038/s41431-024-01631-w
pii: 10.1038/s41431-024-01631-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to European Society of Human Genetics.
Références
Curatolo P. Tuberous sclerosis complex: from basic science to clinical phenotypes. London: Mac Keith Press for the International Child Neurology Association; 2003.
Yang H, Yu Z, Chen X, Li J, Li N, Cheng J, et al. Structural insights into TSC complex assembly and GAP activity on Rheb. Nat Commun. 2021;12:339.
doi: 10.1038/s41467-020-20522-4
pubmed: 33436626
pmcid: 7804450
Jozwiak J, Jozwiak S, Wlodarski P. Possible mechanisms of disease development in tuberous sclerosis. Lancet Oncol. 2008;9:73–9.
doi: 10.1016/S1470-2045(07)70411-4
pubmed: 18177819
Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann NY Acad Sci. 1991;615:125–7.
doi: 10.1111/j.1749-6632.1991.tb37754.x
pubmed: 2039137
Ebrahimi-Fakhari D, Mann LL, Poryo M, Graf N, von Kries R, Heinrich B, et al. Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study. Orphanet J Rare Dis. 2018;13:117.
doi: 10.1186/s13023-018-0870-y
pubmed: 30016967
pmcid: 6050673
Northrup H, Koenig MK, Pearson DA, Au KS. Tuberous sclerosis complex. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJ, Gripp KW, et al., editors. GeneReviews®. Seattle, WA: University of Washington; 1993.
Northrup H, Aronow ME, Bebin EM, Bissler J, Darling TN, De Vries PJ, et al. Updated international tuberous sclerosis Complex diagnostic criteria and surveillance and management recommendations. Pediatr Neurol. 2021;123:50–66.
doi: 10.1016/j.pediatrneurol.2021.07.011
pubmed: 34399110
Canevini MP, Kotulska‐Jozwiak K, Curatolo P, La Briola F, Peron A, Słowińska M, et al. Current concepts on epilepsy management in tuberous sclerosis complex. Am J Med Genet. 2018;178:299–308.
doi: 10.1002/ajmg.c.31652
pubmed: 30255982
on behalf of TOSCA Consortium and TOSCA Investigators, De Vries PJ, Belousova E, Benedik MP, Carter T, Cottin V, et al. TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study. Orphanet J Rare Dis. 2018;13:157.
doi: 10.1186/s13023-018-0901-8
Yates JR, MacLean C, Higgins JNP, Humphrey A, le Marechal K, Clifford M, et al. The Tuberous Sclerosis 2000 Study: presentation, initial assessments and implications for diagnosis and management. Arch Dis Child. 2011;96:1020–5.
doi: 10.1136/adc.2011.211995
pubmed: 21813552
Pearsson K, Björk Werner J, Lundgren J, Gränse L, Karlsson E, Källén K, et al. Childhood tuberous sclerosis complex in southern Sweden: a paradigm shift in diagnosis and treatment. BMC Pediatr. 2023;23:329.
doi: 10.1186/s12887-023-04137-4
pubmed: 37386496
pmcid: 10308728
Yuan S-M. Fetal cardiac tumors: clinical features, management and prognosis. J Perinat Med. 2018;46:115–21.
doi: 10.1515/jpm-2016-0311
pubmed: 28343178
Okmen F, Ekici H, Hortu I, Imamoglu M, Ucar B, Ergenoglu AM, et al. Outcomes of antenatally diagnosed fetal cardiac tumors: a 10-year experience at a single tertiary referral center. J Matern Fetal Neonatal Med. 2022;35:3489–94.
doi: 10.1080/14767058.2020.1822316
pubmed: 32954877
Dragoumi P, O’Callaghan F, Zafeiriou DI. Diagnosis of tuberous sclerosis complex in the fetus. Eur J Paediatr Neurol. 2018;22:1027–34.
doi: 10.1016/j.ejpn.2018.08.005
pubmed: 30279084
Chao AS, Chao A, Wang TH, Chang YC, Chang YL, Hsieh CC, et al. Outcome of antenatally diagnosed cardiac rhabdomyoma: case series and a meta-analysis. Ultrasound Obstet Gynecol. 2008;31:289–95.
doi: 10.1002/uog.5264
pubmed: 18307215
Wortmann SB, Reimer A, Creemers JWT, Mullaart RA. Prenatal diagnosis of cerebral lesions in tuberous sclerosis complex (TSC). Case report and review of the literature. Eur J Paediatr Neurol. 2008;12:123–6.
doi: 10.1016/j.ejpn.2007.06.006
pubmed: 17681840
Isaacs H. Fetal and neonatal cardiac tumors. Pediatr Cardiol. 2004;25:252–73.
doi: 10.1007/s00246-003-0590-4
pubmed: 15360117
Jin N, Wu Y, Meng Q, Luo Q. Prenatal diagnosis of tuberous sclerosis complex: echocardiography, cranial magnetic resonance, and genetic testing of 40 cases with fetal cardiac tumors. Heliyon. 2023;9:e16980.
doi: 10.1016/j.heliyon.2023.e16980
pubmed: 37484232
pmcid: 10361035
Qi Y, Ding H, Huang Y, Zeng Y, Yu L, Liu L, et al. A multidisciplinary approach in prenatal diagnosis of TSC with cardiac rhabdomyoma as the initial symptom. Front Pediatr. 2021;9:628238.
doi: 10.3389/fped.2021.628238
pubmed: 34513752
pmcid: 8429840
Ulm B, Muin D, Scharrer A, Prayer D, Dovjak G, Kasprian G. Prenatal ultrasound and magnetic resonance evaluation and fetal outcome in high‐risk fetal tumors: a retrospective single‐center cohort study over 20 years. Acta Obstet Gynecol Scand. 2020;99:1534–45.
doi: 10.1111/aogs.13933
pubmed: 32525215
Benova B, Petrak B, Kyncl M, Jezdik P, Maulisova A, Jahodova A, et al. Early predictors of clinical and mental outcome in tuberous sclerosis complex: a prospective study. Eur J Paediatr Neurol. 2018;22:632–41.
doi: 10.1016/j.ejpn.2018.03.001
pubmed: 29636221
Fokkema IFAC, Taschner PEM, Schaafsma GCP, Celli J, Laros JFJ, Den Dunnen JT. LOVD v.2.0: the next generation in gene variant databases. Hum Mutat. 2011;32:557–63.
doi: 10.1002/humu.21438
pubmed: 21520333
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
doi: 10.1038/gim.2015.30
pubmed: 25741868
pmcid: 4544753
Kotulska K, Kwiatkowski DJ, Curatolo P, Weschke B, Riney K, Jansen F, et al. Prevention of epilepsy in infants with tuberous sclerosis complex in the EPISTOP Trial. Ann Neurol. 2021;89:304–14.
doi: 10.1002/ana.25956
pubmed: 33180985
Jozwiak S, Słowińska M, Borkowska J, Sadowski K, Łojszczyk B, Domańska-Pakieła D, et al. Preventive antiepileptic treatment in tuberous sclerosis complex: a long-term, prospective trial. Pediatr Neurol. 2019;101:18–25.
doi: 10.1016/j.pediatrneurol.2019.07.008
pubmed: 31481332
Ebrahimi-Fakhari D, Stires G, Hahn E, Krueger D, Franz DN. Prenatal sirolimus treatment for rhabdomyomas in tuberous sclerosis. Pediatr Neurol. 2021;125:26–31.
doi: 10.1016/j.pediatrneurol.2021.09.014
pubmed: 34624607
Cavalheiro S, da Costa MDS, Richtmann R. Everolimus as a possible prenatal treatment of in utero diagnosed subependymal lesions in tuberous sclerosis complex: a case report. Childs Nerv Syst. 2021;37:3897–9.
doi: 10.1007/s00381-021-05218-4
pubmed: 34008055
Uzun O, Wilson DG, Vujanic GM, Parsons JM, De Giovanni JV. Cardiac tumours in children. Orphanet J Rare Dis. 2007;2:11.
doi: 10.1186/1750-1172-2-11
pubmed: 17331235
pmcid: 3225855
Swarr DT, Kaufman B, Fogel MA, Finkel R, Ganesh J. Unusual cardiac “masses” in a newborn with infantile pompe disease. In: SSIEM, editor. JIMD reports – case and research reports, 2012/2. Berlin, Heidelberg: Springer; 2011. pp. 17–20.
Longardt AC, Nonnenmacher A, Graul-Neumann L, Opgen-Rhein B, Henrich W, Bührer C, et al. Fetal intracardiac rhabdomyoma in Beckwith–Wiedemann syndrome: fetal rhabdomyoma. J Clin Ultrasound. 2014;42:569–73.
doi: 10.1002/jcu.22164
pubmed: 24752985
Traisrisilp K, Sirikunalai P, Sirilert S, Chareonsirisuthigul T, Tongsong T. Cardiac rhabdomyoma as a possible new prenatal sonographic feature of Prader–Willi syndrome. J Obstet Gynaecol. 2022;48:239–43.
doi: 10.1111/jog.15073
Racine C, Denommé-Pichon A-S, Engel C, Tran Mau-them F, Bruel A-L, Vitobello A, et al. Multiple molecular diagnoses in the field of intellectual disability and congenital anomalies: 3.5% of all positive cases. J Med Genet. 2024;61:36–46.
Bénit P, Bonnefont J-P, Kara Mostefa A, Francannet C, Munnich A, Ray PF. Denaturing high-performance liquid chromatography (DHPLC)-based prenatal diagnosis for tuberous sclerosis: DHPLC diagnosis for tuberous sclerosis type I. Prenat Diagn. 2001;21:279–83.
doi: 10.1002/pd.55
pubmed: 11288117
Kozlowski P, Roberts P, Dabora S, Franz D, Bissler J, Northrup H, et al. Identification of 54 large deletions/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations. Hum Genet. 2007;121:389–400.
doi: 10.1007/s00439-006-0308-9
pubmed: 17287951
West HD, Nellist M, Brouwer RWW, Van Den Hout-van Vroonhoven MCGN, De Almeida LGD, Hendriks F, et al. Targeted genomic sequencing of TSC1 and TSC2 reveals causal variants in individuals for whom previous genetic testing for tuberous sclerosis complex was normal. Hum Mutat. 2023;2023:1–18.
doi: 10.1155/2023/4899372
Ekong R, Nellist M, Hoogeveen-Westerveld M, Wentink M, Panzer J, Sparagana S, et al. Variants within TSC2 exons 25 and 31 are very unlikely to cause clinically diagnosable tuberous sclerosis. Hum Mutat. 2016;37:364–70.
doi: 10.1002/humu.22951
pubmed: 26703369
pmcid: 4843954
Farach LS, Northrup H, Nellist M, Van Unen L, Hillman P, Klonowska K, et al. Mild TSC phenotype and non-penetrance associated with a frameshift variant in TSC2 prompts caution in evaluating pathogenicity of frameshift variants. Gene. 2023;877:147566.
doi: 10.1016/j.gene.2023.147566
pubmed: 37311496
Hoogeveen-Westerveld M, Ekong R, Povey S, Mayer K, Lannoy N, Elmslie F, et al. Functional assessment of TSC 2 variants identified in individuals with tuberous sclerosis complex. Hum Mutat. 2013;34:167–75.
doi: 10.1002/humu.22202
pubmed: 22903760
Rosengren T, Nanhoe S, De Almeida LGD, Schönewolf-Greulich B, Larsen LJ, Hey CAB, et al. Mutational analysis of TSC1 and TSC2 in Danish patients with tuberous sclerosis complex. Sci Rep. 2020;10:9909.
doi: 10.1038/s41598-020-66588-4
pubmed: 32555378
pmcid: 7303179
Kobayashi T, Minowa O, Kuno J, Mitani H, Hino O, Noda T. Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line TSC2 mutation in mice. Cancer Res. 1999;59:1206–11.
pubmed: 10096549
Hoogeveen‐Westerveld M, Wentink M, Van Den Heuvel D, Mozaffari M, Ekong R, Povey S, et al. Functional assessment of variants in the TSC1 and TSC2 genes identified in individuals with tuberous sclerosis complex. Hum Mutat. 2011;32:424–35.
doi: 10.1002/humu.21451
pubmed: 21309039
Tyburczy ME, Dies KA, Glass J, Camposano S, Chekaluk Y, Thorner AR, et al. Mosaic and intronic mutations in TSC1/TSC2 explain the majority of TSC patients with no mutation identified by conventional testing. PLoS Genet. 2015;11:e1005637.
doi: 10.1371/journal.pgen.1005637
pubmed: 26540169
pmcid: 4634999
Wang S, Sun H, Wang J, Gu X, Han L, Wu Y et al. Detection of TSC1/TSC2 mosaic variants in patients with cardiac rhabdomyoma and tuberous sclerosis complex by hybrid‐capture next‐generation sequencing. Mol Genet Genomic Med. 2021;9. https://doi.org/10.1002/mgg3.1802 .